Covered recipient · General Payments record
JEFF D CHANCELLOR
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$9,653.81
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.02 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $101.59 | 4 |
| Sumitomo Pharma America, Inc. | $43.46 | 2 |
| Organon LLC | $22.52 | 1 |
| Meditrina | $19.71 | 1 |
| Evofem Biosciences, Inc. | $19.45 | 1 |
| PFIZER INC. | $18.76 | 1 |
| Hologic Sales and Service, LLC | $17.90 | 1 |
| Astellas Pharma US Inc | $16.40 | 1 |
| Exeltis, USA Inc. | $16.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.06 | 1 |
| Biogen, Inc. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.47 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103438690 | CMS |
| ABBVIE INC. | $33.95 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103438692 | CMS |
| ABBVIE INC. | $22.37 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103438694 | CMS |
| ABBVIE INC. | $22.80 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103438696 | CMS |
| Astellas Pharma US Inc | $16.40 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139267602 | CMS |
| Biogen, Inc. | $13.17 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870798 | CMS |
| Boston Scientific Corporation | $14.06 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092613826 | CMS |
| Evofem Biosciences, Inc. | $19.45 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091271675 | CMS |
| Exeltis, USA Inc. | $16.00 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149990335 | CMS |
| Hologic Sales and Service, LLC | $17.90 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084922254 | CMS |
| Meditrina | $19.71 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267562 | CMS |
| Organon Llc | $22.52 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215991 | CMS |
| PFIZER INC. | $18.76 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131786704 | CMS |
| Sumitomo Pharma America, Inc. | $18.31 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148836593 | CMS |
| Sumitomo Pharma America, Inc. | $25.15 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148836595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.